Drug details

Plenaxis (abarelix)

type of Gonadotropin Releasing Hormone Antagonists

Plenaxis (abarelix) for Injectable Suspension inhibits gonadotropin releasing-hormone (GnRH) and is used in the palliative treatment of advanced prostate cancer. The brand name Plenaxis is discontinued but generic versions may be available.

The drug is often used to treat Prostate cancer .

This drug may have the following side effects:

• nausea
• headache
• dizziness
• upper respiratory tract infection.
• 
  hot flashes
• sleep disturbances
• breast enlargement or pain
• nipple tenderness
• diarrhea or constipation
• swelling of extremities
• fatigue
• changes with or difficulty urinating
• urinary tract infection or

The following drugs are related to Plenaxis, either as a replacement or used together:

• Casodex (bicalutamide)
• Eligard (leuprolide acetate)
• Eulexin (flutamide)
• Zoladex 10.8 mg (goserelin acetate implant)
• Zoladex 3.6 (goserelin acetate implant)
• Lupron Depot 11.25 mg (leuprolide acetate for depot suspension)
• Lupron Depot 7.5 mg (leuprolide acetate for depot suspension)
• Lupron Depot (leuprolide acetate for depot suspension)
• Lupron Depot 22.5 (leuprolide acetate for depot suspension injection)
• Viadur (leuprolide acetate implant)
• Lupron (leuprolide acetate injection)
• Lupron Depot 3.75 mg (leuprolide acetate injection)
• Nilandron (nilutamide tablets)
• Trelstar (triptorelin pamoate for injectable suspension)
• Trelstar Depot (triptorelin pamoate for injectable suspension)
• Trelstar LA (triptorelin pamoate for injectable suspension)